» Articles » PMID: 18588940

The Role of Reactive Oxygen Species in Arsenite and Monomethylarsonous Acid-induced Signal Transduction in Human Bladder Cells: Acute Studies

Overview
Journal Toxicology
Publisher Elsevier
Specialty Toxicology
Date 2008 Jul 1
PMID 18588940
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Arsenicals are known to induce ROS, which can lead to DNA damage, oxidative stress, and carcinogenesis. A human urothelial cell line, UROtsa, was used to study the effects of arsenicals on the human bladder. Arsenite [As(III)] and monomethylarsonous acid [MMA(III)] induce oxidative stress in UROtsa cells after exposure to concentrations as low as 1 microM and 50 nM, respectively. Previous research has implicated ROS as signaling molecules in the MAPK signaling pathway. As(III) and MMA(III) have been shown to increase phosphorylation of key proteins in the MAPK signaling cascade downstream of ErbB2. Both Src phosphorylation (p-Src) and cyclooxygenase-2 (COX-2) are induced after exposure to 50 nM MMA(III) and 1 microM As(III). These data suggest that ROS production is a plausible mechanism for the signaling alterations seen in UROtsa cells after acute arsenical exposure. To determine importance of ROS in the MAPK cascade and its downstream induction of p-Src and COX-2, specific ROS antioxidants (both enzymatic and non-enzymatic) were used concomitantly with arsenicals. COX-2 protein and mRNA was shown to be much more influenced by altering the levels of ROS in cells, particularly after MMA(III) treatment. The antioxidant enzyme superoxide dismutase (SOD) effectively blocked both As(III)-and MMA(III)- associated COX-2 induction. The generation of ROS and subsequent altered signaling did lead to changes in protein levels of SOD, which were detected after treatment with either 1 microM As(III) or 50 nM MMA(III). These data suggest that the generation of ROS by arsenicals may be a mechanism leading to the altered cellular signaling seen after low-level arsenical exposure.

Citing Articles

Ethanol extract of (Gaertn, F) leaves protects against sodium arsenite - induced toxicity in male wistar rats.

Oyibo A, Gbadegesin M, Odunola O Toxicol Rep. 2021; 8:774-784.

PMID: 33854955 PMC: 8027566. DOI: 10.1016/j.toxrep.2021.03.035.


Rbfox2 dissociation from stress granules suppresses cancer progression.

Choi S, Sa M, Cho N, Kim K, Park S Exp Mol Med. 2019; 51(4):1-12.

PMID: 31028247 PMC: 6486603. DOI: 10.1038/s12276-019-0246-y.


Arsenite Targets the RING Finger Domain of Rbx1 E3 Ubiquitin Ligase to Inhibit Proteasome-Mediated Degradation of Nrf2.

Jiang J, Tam L, Wang P, Wang Y Chem Res Toxicol. 2018; 31(5):380-387.

PMID: 29658272 PMC: 6154506. DOI: 10.1021/acs.chemrestox.8b00062.


Solid surface photochemistry of montmorillonite: mechanisms for the arsenite oxidation under UV-A irradiation.

Yuan Y, Wang Y, Ding W, Li J, Wu F Environ Sci Pollut Res Int. 2015; 23(2):1035-43.

PMID: 26194238 DOI: 10.1007/s11356-015-5017-2.


Thymoquinone prevents and ameliorates dextran sulfate sodium-induced colitis in mice.

Lei X, Liu M, Yang Z, Ji M, Guo X, Dong W Dig Dis Sci. 2012; 57(9):2296-303.

PMID: 22476588 DOI: 10.1007/s10620-012-2156-x.


References
1.
Wang T, Jan K, Wang A, Gurr J . Trivalent arsenicals induce lipid peroxidation, protein carbonylation, and oxidative DNA damage in human urothelial cells. Mutat Res. 2006; 615(1-2):75-86. DOI: 10.1016/j.mrfmmm.2006.10.003. View

2.
Eblin K, Bredfeldt T, Buffington S, Gandolfi A . Mitogenic signal transduction caused by monomethylarsonous acid in human bladder cells: role in arsenic-induced carcinogenesis. Toxicol Sci. 2006; 95(2):321-30. DOI: 10.1093/toxsci/kfl160. View

3.
Wang X, Sun Z, Chen W, Eblin K, Gandolfi J, Zhang D . Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity. Toxicol Appl Pharmacol. 2007; 225(2):206-13. PMC: 2610476. DOI: 10.1016/j.taap.2007.07.016. View

4.
Bredfeldt T, Jagadish B, Eblin K, Mash E, Gandolfi A . Monomethylarsonous acid induces transformation of human bladder cells. Toxicol Appl Pharmacol. 2006; 216(1):69-79. PMC: 2851136. DOI: 10.1016/j.taap.2006.04.011. View

5.
Oshiro M, Kim C, Wozniak R, Junk D, Munoz-Rodriguez J, Burr J . Epigenetic silencing of DSC3 is a common event in human breast cancer. Breast Cancer Res. 2005; 7(5):R669-80. PMC: 1242132. DOI: 10.1186/bcr1273. View